{"id":457468,"date":"2021-03-15T08:04:11","date_gmt":"2021-03-15T12:04:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=457468"},"modified":"2021-03-15T08:04:11","modified_gmt":"2021-03-15T12:04:11","slug":"enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/","title":{"rendered":"Enveric Biosciences to Participate in Upcoming Investor Conferences in March"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p \/>\n<p>\n        <span class=\"xn-location\">NAPLES, Fla.<\/span>, <span class=\"xn-chron\">March 15, 2021<\/span> \/PRNewswire\/ &#8212; <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3096365-1&amp;h=1399728030&amp;u=https%3A%2F%2Fwww.enveric.com%2F&amp;a=Enveric+Biosciences\" rel=\"nofollow noopener noreferrer\">Enveric Biosciences<\/a> (NASDAQ: ENVB) (&#8220;Enveric&#8221; or the &#8220;Company&#8221;), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that <span class=\"xn-person\">David Johnson<\/span>, Chairman and Chief Executive Officer, will participate in two upcoming investor conferences in March: <\/p>\n<ul type=\"disc\">\n<li>M Vest and Maxim Group Inaugural Emerging Growth Conference to be held virtually on <span class=\"xn-chron\">Thursday, March 18, 2021<\/span>. To attend the conference, register <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3096365-1&amp;h=3157448255&amp;u=https%3A%2F%2Fwww.m-vest.com%2Fevents%2F2021-emerging-growth-virtual-conference&amp;a=here\" rel=\"nofollow noopener noreferrer\">here<\/a>\n<\/li>\n<li>Benzinga&#8217;s Biotech Small Cap Conference to be held virtually on <span class=\"xn-chron\">Thursday, March 25, 2021<\/span>. Mr. Johnson will present at <span class=\"xn-chron\">12:30 p.m. ET<\/span>. In addition to the corporate presentation, Mr. Johnson will participate on the panel <i>The Natural Solutions: Cannabis &amp; Cannabinoids<\/i> at <span class=\"xn-chron\">11:40 a.m. ET<\/span>. To attend the conference, register <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3096365-1&amp;h=1584606194&amp;u=https%3A%2F%2Fwww.benzinga.com%2Fevents%2F&amp;a=here\" rel=\"nofollow noopener noreferrer\">here<\/a>.<\/li>\n<\/ul>\n<p>For more information regarding the conference, or to schedule a one-on-one meeting with Enveric&#8217;s management team, please contact KCSA Strategic Communications at <a target=\"_blank\" href=\"mailto:EnvericBio@kcsa.com\" rel=\"nofollow noopener noreferrer\">EnvericBio@kcsa.com<\/a>\u00a0or your Maxim Group and Benzinga representatives directly. <\/p>\n<p>\n        <b>About Enveric Biosciences<br \/><\/b>Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy. For more information, please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3096365-1&amp;h=2418247803&amp;u=https%3A%2F%2Fwww.enveric.com%2F&amp;a=https%3A%2F%2Fwww.enveric.com%2F\" rel=\"nofollow noopener noreferrer\">https:\/\/www.enveric.com\/<\/a>.<\/p>\n<p>\n        <b>Investor Contacts<br \/><\/b><br \/>\n        <span class=\"xn-person\">Valter Pinto<\/span> \/ Allison Soss<br \/>KCSA Strategic Communications<br \/>212.896.1254 \/ 212.896.1267<br \/><a target=\"_blank\" href=\"mailto:valter@kcsa.com\" rel=\"nofollow noopener noreferrer\">valter@kcsa.com<\/a>\u00a0\/ <a target=\"_blank\" href=\"mailto:asoss@kcsa.com\" rel=\"nofollow noopener noreferrer\">asoss@kcsa.com<\/a><\/p>\n<p>\n        <b>Media Contacts<br \/><\/b><br \/>\n        <span class=\"xn-person\">Caitlin Kasunich<\/span> \/ <span class=\"xn-person\">Raquel Cona<\/span><br \/>KCSA Strategic Communications<br \/>212.896.1241 \/ 516.779.2630<br \/><a target=\"_blank\" href=\"mailto:ckasunich@kcsa.com\" rel=\"nofollow noopener noreferrer\">ckasunich@kcsa.com<\/a>\u00a0\/ <a target=\"_blank\" href=\"mailto:rcona@kcsa.com\" rel=\"nofollow noopener noreferrer\">rcona@kcsa.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY09052&amp;sd=2021-03-15\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march-301246977.html\">http:\/\/www.prnewswire.com\/news-releases\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march-301246977.html<\/a><\/p>\n<p>SOURCE  Enveric Biosciences<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY09052&amp;Transmission_Id=202103150800PR_NEWS_USPR_____NY09052&amp;DateId=20210315\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NAPLES, Fla., March 15, 2021 \/PRNewswire\/ &#8212; Enveric Biosciences (NASDAQ: ENVB) (&#8220;Enveric&#8221; or the &#8220;Company&#8221;), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that David Johnson, Chairman and Chief Executive Officer, will participate in two upcoming investor conferences in March: M Vest and Maxim Group Inaugural Emerging Growth Conference to be held virtually on Thursday, March 18, 2021. To attend the conference, register here Benzinga&#8217;s Biotech Small Cap Conference to be held virtually on Thursday, March 25, 2021. Mr. Johnson will present at 12:30 p.m. ET. In addition to the corporate presentation, Mr. Johnson will participate on the panel The Natural Solutions: Cannabis &amp; Cannabinoids at 11:40 a.m. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Enveric Biosciences to Participate in Upcoming Investor Conferences in March&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-457468","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Enveric Biosciences to Participate in Upcoming Investor Conferences in March - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enveric Biosciences to Participate in Upcoming Investor Conferences in March - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NAPLES, Fla., March 15, 2021 \/PRNewswire\/ &#8212; Enveric Biosciences (NASDAQ: ENVB) (&#8220;Enveric&#8221; or the &#8220;Company&#8221;), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that David Johnson, Chairman and Chief Executive Officer, will participate in two upcoming investor conferences in March: M Vest and Maxim Group Inaugural Emerging Growth Conference to be held virtually on Thursday, March 18, 2021. To attend the conference, register here Benzinga&#8217;s Biotech Small Cap Conference to be held virtually on Thursday, March 25, 2021. Mr. Johnson will present at 12:30 p.m. ET. In addition to the corporate presentation, Mr. Johnson will participate on the panel The Natural Solutions: Cannabis &amp; Cannabinoids at 11:40 a.m. &hellip; Continue reading &quot;Enveric Biosciences to Participate in Upcoming Investor Conferences in March&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-15T12:04:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY09052&amp;sd=2021-03-15\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Enveric Biosciences to Participate in Upcoming Investor Conferences in March\",\"datePublished\":\"2021-03-15T12:04:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY09052&amp;sd=2021-03-15\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/\",\"name\":\"Enveric Biosciences to Participate in Upcoming Investor Conferences in March - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY09052&amp;sd=2021-03-15\",\"datePublished\":\"2021-03-15T12:04:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY09052&amp;sd=2021-03-15\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY09052&amp;sd=2021-03-15\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enveric Biosciences to Participate in Upcoming Investor Conferences in March\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enveric Biosciences to Participate in Upcoming Investor Conferences in March - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/","og_locale":"en_US","og_type":"article","og_title":"Enveric Biosciences to Participate in Upcoming Investor Conferences in March - Market Newsdesk","og_description":"PR Newswire NAPLES, Fla., March 15, 2021 \/PRNewswire\/ &#8212; Enveric Biosciences (NASDAQ: ENVB) (&#8220;Enveric&#8221; or the &#8220;Company&#8221;), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that David Johnson, Chairman and Chief Executive Officer, will participate in two upcoming investor conferences in March: M Vest and Maxim Group Inaugural Emerging Growth Conference to be held virtually on Thursday, March 18, 2021. To attend the conference, register here Benzinga&#8217;s Biotech Small Cap Conference to be held virtually on Thursday, March 25, 2021. Mr. Johnson will present at 12:30 p.m. ET. In addition to the corporate presentation, Mr. Johnson will participate on the panel The Natural Solutions: Cannabis &amp; Cannabinoids at 11:40 a.m. &hellip; Continue reading \"Enveric Biosciences to Participate in Upcoming Investor Conferences in March\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-15T12:04:11+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY09052&amp;sd=2021-03-15","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Enveric Biosciences to Participate in Upcoming Investor Conferences in March","datePublished":"2021-03-15T12:04:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY09052&amp;sd=2021-03-15","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/","name":"Enveric Biosciences to Participate in Upcoming Investor Conferences in March - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY09052&amp;sd=2021-03-15","datePublished":"2021-03-15T12:04:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY09052&amp;sd=2021-03-15","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY09052&amp;sd=2021-03-15"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-march\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Enveric Biosciences to Participate in Upcoming Investor Conferences in March"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/457468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=457468"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/457468\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=457468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=457468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=457468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}